Respiratory syncytial virus (RSV ... been based on moderate to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays); however ...
Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...
MANILA, Philippines — Respiratory Syncytial ... transmit the virus for extended periods. “Our seniors are particularly susceptible and vulnerable because, in Philippine culture, they often ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...
CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...
About mRNA-1345 (Respiratory Syncytial Virus Vaccine ... on the surface of the virus and is required for infection by helping the virus to enter host cells. The prefusion conformation of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback